لینسیتینیب

Also known as OSI-9606, Linsitinib

Linsitinib is an experimental drug candidate for the treatment of various types of cancer. It is an inhibitor of the insulin receptor and of the insulin-like growth factor 1 receptor (IGF-1R). This prevents tumor cell proliferation and induces tumor cell apoptosis.

In the Vinony graph

Within Vinony's link graph, لینسیتینیب is referenced by 353 other articles, and connects out to medication, digital object identifier and chemical formula.

It sits within the topics Antineoplastic drugs, Astellas Pharma and Chembox image size set.

Its subject is documented across 5 Wikipedia language editions.

Chemical data

Drug data · ChEMBL

Max clinical phase: Phase 3
Molecule type: Small molecule
Indications: neoplasm, small cell lung carcinoma, hepatocellular carcinoma, prostate adenocarcinoma

via ChEMBL · EBI

Wikidata facts

Mass: 421.19026035599995

Show 4 more facts

isomeric SMILES: C[C@]1(C[C@@H](C1)C=2N3C(C(=NC=C3)N)=C(N2)C4=CC5=NC(=CC=C5C=C4)C6=CC=CC=C6)O
canonical SMILES: CC1(CC(C1)C=2N3C(C(=NC=C3)N)=C(N2)C4=CC5=NC(=CC=C5C=C4)C6=CC=CC=C6)O
chemical formula: C₂₆H₂₃N₅O
Commons category: Linsitinib

Sources (3)

via Wikidata · CC0